Myopia
Conditions
Interventions
Good control effect group (300 cases, the annual progression in myopia should not exceed 0.25D, or the annual progression in myopia should be at least 50%, or the annual increase in axial length shoul
Poor control effect group (300 cases, annual increase in myopia reaching or exceeding 0.75 D or annual increase in axial length reaching or exceeding 0.4 mm)):NA
Observation group:None
Sponsors
Affiliated Eye Hospital of Wenzhou Medical University
Eligibility
Sex/Gender
All
Age
6 Years to 10 Years
Inclusion criteria
Inclusion criteria: 1.The age at which one begins to wear myopia control spectacles is 6-10 years old, and one has been or can wear myopia control spectacles regularly for one year; 2.Baseline noncycloplegic subjective manifest refraction: -6.00 D <= binocular equivalent spherical lens degree <=+1.50D, astigmatism <= 1.50D, anisometropia <= 1.50D.
Exclusion criteria
Exclusion criteria: Individuals with other ocular diseases, such as uveitis and various inflammatory conditions, glaucoma, cataracts, ocular fundus diseases, ocular tumors, and any ocular lesions affecting visual function; patients with systemic diseases causing immune deficiency (such as diabetes, Down syndrome, rheumatoid arthritis, psychiatric patients, or other diseases deemed unsuitable for wearing frame glasses by researchers); amblyopia, intermittent strabismus, and manifest strabismus; individuals who have used atropine, guanlansil, and other myopia control medications during the first year of wearing myopia control spectacles; individuals who have used rigid gas permeable (RGP) contact lenses (including care products), multifocal contact lenses, progressive multifocal lenses, and other specially designed myopia control lenses, phototherapy devices, low-concentration atropine-based medications, etc., within 3 months before wearing myopia control spectacles; individuals who have undergone accommodation training or traditional Chinese medicine ear acupoint bean pressing therapy, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Annual growth of axial length;Spherical equivalent;High throughput sequencing Genetic testing; | — |
Countries
China
Contacts
Public ContactXia Ruijing
Affiliated Eye Hospital of Wenzhou Medical University
Outcome results
None listed